Akebia Therapeutics
AKBA
#9495
Rank
A$0.19 B
Marketcap
A$0.70
Share price
-4.78%
Change (1 day)
-73.96%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): A-$0.23

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.24. In 2025 the company made an earnings per share (EPS) of A-$0.02959 an increase over its 2024 EPS that were of A-$0.49.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.23688.83%
2025A-$0.02959-93.94%
2024A-$0.49-16.83%
2023A-$0.59-23.7%
2022A-$0.77-69.41%
2021A-$2.51-38.63%
2020A-$4.1017.37%
2019A-$3.492.79%
2018A-$3.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.88-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.77-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$25.71-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.91 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA